Our Featured Experts

Sara A. Hurvitz, MD
Dr. Hurvitz on the Evolution of Treatment in Metastatic HER2+ Breast Cancer
Sara A. Hurvitz, MD, associate professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA) medical director of the Jonsson Comprehensive Cancer Center Clinical Research Unit, co-director of the Santa Monica-UCLA Outpatient Oncology Practices, and director, Breast Cancer Clinical Trials Program, UCLA, discusses the evolution of treatment in metastatic HER2-positive breast cancer.
Cristina Gasparetto, MD
Oncology Specialists
Publication Bottom Border
Border Publication
x